Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
The Clinical Picture

Methemoglobinemia in an HIV patient

Riva Raiker, MD, William C. Lippert, MD, MPH and Romil Chadha, MD, MPH, FACP, SFHM
Cleveland Clinic Journal of Medicine March 2018, 85 (3) 186-187; DOI: https://doi.org/10.3949/ccjm.85a.17004
Riva Raiker
Junior Resident, Department of Internal Medicine, University of Kentucky Medical Center, Lexington, KY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William C. Lippert
Senior Resident, Department of Internal Medicine, University of Kentucky Medical Center, Lexington, KY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Romil Chadha
Assistant Professor of Medicine, University of Kentucky Medical Center, Lexington, KY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

A 45-year-old man with known human immunodeficiency virus infection presented with a 5-day history of dyspnea. When his dyspnea had become symptomatic, he had restarted his home dapsone prophylaxis, but his dyspnea had progressively worsened, and his urine became dark.

On presentation to our institution, he was tachycardic, tachypneic, hypoxic, and cyanotic (Figure 1). Chest radiography revealed multifocal bilateral airspace opacities. He was started on vancomycin and piperacillin-tazobactam for treatment of presumed pneumonia, and his dapsone was continued for prophylaxis against Pneumocystis jirovecii pneumonia.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

The patient’s hands on presentation (top) and after treatment with intravenous methylene blue (bottom).

During the next several hours, his hypoxia worsened, and his peripheral capillary oxygen saturation was 87% despite use of a Venturi mask at a 35% fraction of inspired oxygen. Arterial blood gas testing revealed an elevated partial pressure of oxygen (143 mm Hg) and chocolate-brown colored arterial blood. Due to the low peripheral capillary oxygen saturation, high partial pressure of oxygen, and abnormal color of his blood (Figure 2), serum methemo-globin testing was ordered and revealed a concentration of 22.9% (normal value < 1.5%).

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

The patient’s arterial blood on presentation (left) compared with a sample of normal arterial blood (right).

Based on these test results, the patient’s dapsone was stopped and replaced with atovaquone. Intravenous infusion of methylene blue was started, with subsequent improvement of the hypoxia and cyanosis (Figure 1). His urine became green, but it returned to a normal color in a matter of hours. He was ultimately diagnosed with P jirovecii pneumonia and completed a course of atovaquone with total resolution of his symptoms.

THE MECHANISMS BEHIND METHEMOGLOBINEMIA

Heme iron is normally in the ferrous state (Fe2+), which allows for hemoglobin to carry oxygen and release it to tissues.1 Exposure to an oxidative stress can lead to methemoglobin-emia from an increase in abnormal hemoglobin that contains iron in a ferric state (Fe3+).1,2

Methemoglobin reduces oxygen-carrying capacity in two ways: it is unable to carry oxygen, and its presence shifts the oxy gen dissociation curve to the left, causing any remaining normal hemoglobin to be unable to release oxygen to the tissues.1,2

Causes of acquired methemoglobinemia include topical anesthetics (eg, benzocaine, lidocaine) and antibiotics (eg, dapsone).2,3 Signs and symptoms include cyanosis, headache, fatigue, dyspnea, lethargy, respiratory distress, and dark-colored urine.1,2

MANAGEMENT

Treatment consists of intravenous methylene blue, which reduces the hemoglobin from a ferric state to a ferrous state.1–4 Methylene blue is a water-soluble dye excreted primarily in the urine, and common side effects include dizziness, nausea, and green urine.5–7 The blue pigments from methylene blue combine with urobilin (a yellow pigment in the urine), producing a green color.7 This is not pathological and requires no treatment, as the urine returns to normal color after the body fully excretes the dye.5–7

If intravenous methylene blue fails to produce a response, other treatments to consider include hemodialysis, blood transfusion, exchange transfusion, and hyperbaric oxygen therapy.2

  • Copyright © 2018 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

  1. ↵
    1. Umbreit J
    . Methemoglobin—it’s not just blue: a concise review. Am J Hematol 2007; 82:134–144.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Ash-Bernal R,
    2. Wise R,
    3. Wright SM
    . Acquired methemoglo-binemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore) 2004; 83:265–273.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Coleman MD,
    2. Coleman NA
    . Drug-induced methaemoglo-binaemia. Treatment issues. Drug Saf 1996; 14:394–405.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Sikka P,
    2. Bindra VK,
    3. Kapoor S,
    4. Jain V,
    5. Saxena KK
    . Blue cures blue but be cautious. J Pharm Bioallied Sci 2011; 3:543–545.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Stratta P,
    2. Barbe MC
    . Images in clinical medicine. Green urine. N Engl J Med 2008; 358:e12.
    OpenUrlCrossRefPubMed
    1. Miri-Aliabad G
    . Green urine secondary to methylene blue. Indian J Pediatr 2014; 81:1255–1256.
    OpenUrl
  6. ↵
    1. Prakash S,
    2. Saini S,
    3. Mullick P,
    4. Pawar M
    . Green urine: a cause for concern? J Anaesthesiol Clin Pharmacol 2017; 33:128–130.
    OpenUrl
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 85 (3)
Cleveland Clinic Journal of Medicine
Vol. 85, Issue 3
1 Mar 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Methemoglobinemia in an HIV patient
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Methemoglobinemia in an HIV patient
Riva Raiker, William C. Lippert, Romil Chadha
Cleveland Clinic Journal of Medicine Mar 2018, 85 (3) 186-187; DOI: 10.3949/ccjm.85a.17004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Methemoglobinemia in an HIV patient
Riva Raiker, William C. Lippert, Romil Chadha
Cleveland Clinic Journal of Medicine Mar 2018, 85 (3) 186-187; DOI: 10.3949/ccjm.85a.17004
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • THE MECHANISMS BEHIND METHEMOGLOBINEMIA
    • MANAGEMENT
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Tinea incognito
  • Prolonged venous filling time and dependent rubor in a patient with peripheral artery disease
  • Sarcoidosis with diffuse purplish erythematous plaques on the hands
Show more The Clinical Picture

Similar Articles

Subjects

  • Dermatology
  • Drug Therapy
  • Hematology
  • Infectious Diseases

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire